Members of our team had the opportunity to present a new poster abstract at the 2023 NASP Annual Meeting & Expo, which was held from September 18-21, at AMCP Nexus 2023 from October 16-19, and at the 2023 NCODA International Fall Summit, held October 25-27.
Background
- Health system specialty pharmacy (HSSP) pharmacists embedded with oncology clinics can utilize their clinical expertise and promptly intervene when medication therapy issues arise.
- Pharmacist interventions have been linked to improved patient outcomes and have cost savings implications.
- Average cost savings per pharmacist intervention for oncology medications ranges from ~$8,100 to ~$11,000.
- Identifying cost savings practices by pharmacists within HSSP clinics is crucial to understand the benefits provided to patients and the healthcare system.
Objectives
To determine the impact of HSSP pharmacist interventions on cost savings of oral oncolytics at a community oncology center.
Read about the team's findings by downloading the Outcomes Study below.
Download the abstract: